Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Stem Cell is a healthcare and biotechnology entity focused on the clinical application of regenerative medicine. The organization specializes in providing stem cell-based therapies, particularly utilizing mesenchymal stem cells derived from adipose tissue or bone marrow to treat orthopedic and degenerative conditions. Their services primarily target patients with osteoarthritis, chronic joint pain, and sports-related injuries, aiming to provide non-surgical alternatives for tissue repair. In addition to clinical services, the center often engages in patient-funded research and data collection to evaluate the efficacy of various cell therapy protocols. The company operates through a network of specialized clinics and maintains a focus on advancing the accessibility of regenerative treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Stem Cell.